SOTAGLIFLOZIN REDUCES STROKE OUTCOMES IN PATIENTS WITH DIABETES AND CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Aggarwal, Rahul [1 ]
Bhatt, Deepak L. [1 ]
Szarek, Michael [1 ]
Davies, Michael [1 ]
Banks, Phillip [1 ]
Pitt, Bertram [1 ]
Steg, Philippe Gabriel [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1116-13
引用
收藏
页码：1733 / 1733
页数：1
相关论文
共 50 条
  • [1] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Deepak L.Bhatt
    四川生理科学杂志, 2020, 42 (04) : 391 - 391
  • [2] Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease
    Bhatt, Deepak L.
    Szarek, Michael
    Pitt, Bertram
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Cherney, David Z. I.
    Dwyer, Jamie P.
    Scirica, Benjamin M.
    Bailey, Clifford J.
    Diaz, Rafael
    Ray, Kausik K.
    Udell, Jacob A.
    Lopes, Renato D.
    Lapuerta, Pablo
    Steg, P. Gabriel
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02): : 129 - 139
  • [3] Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease
    Cherney, David Z. I. L.
    Bhatt, Deepak
    Szarek, Michael
    Sun, Franklin
    Girard, Manon J.
    Davies, Michael
    Pitt, Bertram
    Steg, Ph. Gabriel
    DIABETES OBESITY & METABOLISM, 2023, 25 (11): : 3410 - 3414
  • [4] Sotagliflozin Significantly Reduces CV Death and Heart Failure-related Outcomes in Patients with Type 2 Diabetes, Chronic Kidney Disease, and History of Heart Failure
    Hardin, M. B.
    Carroll, A. K.
    Davies, M. J.
    Girard, M.
    Banks, P.
    Pitt, B.
    Steg, P. G.
    Bhatt, D. L.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [5] Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease
    Cherney, David Z. I.
    Ferrannini, Ele
    Umpierrez, Guillermo E.
    Peters, Anne L.
    Rosenstock, Julio
    Powell, David R.
    Davies, Michael J.
    Banks, Phillip
    Agarwal, Rajiv
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1646 - 1657
  • [6] Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4
    Sridhar, Vikas S.
    Davies, Michael J.
    Banks, Phillip
    Girard, Manon
    Carroll, Amy K.
    Cherney, David Z. I.
    DIABETES OBESITY & METABOLISM, 2024,
  • [7] Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes
    Farkouh, Michael E.
    Sidhu, Mandeep S.
    Brooks, Maria M.
    Vlachos, Helen
    Boden, William E.
    Frye, Robert L.
    Hartigan, Pamela
    Siami, F. S.
    Bittner, Vera A.
    Chaitman, Bernard R.
    Mancini, John
    Fuster, Valentin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (04) : 400 - 411
  • [8] Role of chronic kidney disease and atrial fibrillation in outcomes of patients with ischemic stroke
    Khan, A. A.
    Lip, G. Y. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (08) : 1009 - 1010
  • [9] Association of chronic kidney disease with outcomes in acute stroke
    Tung, Iong Man
    Barlas, Raphae S.
    Vart, Priya
    Bettencourt-Silva, Joao H.
    Clark, Allan B.
    Sawanyawisuth, Kittisak
    Kongbunkiat, Kannikar
    Kasemsap, Narongrit
    Tiamkao, Somsak
    Myint, Phyo K.
    ACTA NEUROLOGICA BELGICA, 2021, 121 (05) : 1241 - 1246
  • [10] Association of chronic kidney disease with outcomes in acute stroke
    Iong Man Tung
    Raphae S. Barlas
    Priya Vart
    Joao H. Bettencourt-Silva
    Allan B. Clark
    Kittisak Sawanyawisuth
    Kannikar Kongbunkiat
    Narongrit Kasemsap
    Somsak Tiamkao
    Phyo K. Myint
    Acta Neurologica Belgica, 2021, 121 : 1241 - 1246
12345